Adoptivnaya immunoterapiya limfotsitami allotransplantanta pecheni vyzyvaet anti-HCV reaktsiyu posle peresadki pecheni u lyudey i gumanizirovannykh myshey

M A Reutin

Genes & Cells ›› 2010, Vol. 5 ›› Issue (1) : 26 -28.

PDF
Genes & Cells ›› 2010, Vol. 5 ›› Issue (1) : 26 -28. DOI: 10.23868/gc121471
Articles
other

Adoptivnaya immunoterapiya limfotsitami allotransplantanta pecheni vyzyvaet anti-HCV reaktsiyu posle peresadki pecheni u lyudey i gumanizirovannykh myshey

Author information +
History +
PDF

Cite this article

Download citation ▾
M A Reutin. Adoptivnaya immunoterapiya limfotsitami allotransplantanta pecheni vyzyvaet anti-HCV reaktsiyu posle peresadki pecheni u lyudey i gumanizirovannykh myshey. Genes & Cells, 2010, 5(1): 26-28 DOI:10.23868/gc121471

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Welch C.S. A Note on transplantation of the whole liver in dogs. Transplant. Transplant Bull. 1955; 2: 54.

[2]

Starzl Т.Е., MarchioroT.L, Vonkaulla K.N. et al. Homotransplantation of the liver in humas. Surg. Gynecol. Obstet. 1963; 117: 659-76.

[3]

Starzl Т.Е., Klintmalm G.B., Porter K.A., Iwatsuki S., Schroeter G.P. Liver transplantation with use of cyclosporin a and prednisone. N. Engl. J. Med. 1981; 305(5): 266-9.

[4]

Ермолов A.C., Чжао А.В., Мусселиус С.Г. и др. Первый опыт трансплантации печени в НИИ скорой помощи им. Н.В. Склифосовского. Рос. журн. гастроэнтерологии, гепатологий, колопроктологии 2002; 1: 38-46.

[5]

Андрейцева О.И.. Возможности ортотопической трансплантаций печени при лечении больных с терминальными поражениями печени. Consilium medicum 2004; 06: 414-21.

[6]

Jain A., Reyes J., Kashyap R. et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann. Surg. 2000; 232; 490-500.

[7]

Borel J.F., Feurer C, Gubler H.U., Stahelin H. Biological effect of cyclosporine A: new antilymphocytic agent. Agents Actions 1976; 6: 468-75.

[8]

Brown R.S. Hepatitis С and liver transplantation. Nature 2005; 436: 973-8.

[9]

Mazzaferro V., Regalia E., Doci R. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996; 334: 693-9.

[10]

Шерлок LU., Дули Дж. Заболевания печени и желчных путей: Практическое руководство; пер. с англ. Под ред. Апросиной З.Г., Мухина Н.А. Москва: ГЭОТАР-МЕД; 2002.

[11]

First human gets new antibody aimed at hepatitis С virus Phase 1 clinical trial in healthy subjects designed to advance novel treatment to prevent. University of Massachusetts Medical School press release. August 6, 2009.

[12]

Garcia-Retortillo M., Forns X., Feliu A. et al. Hepatitis С virus kinetics during and immediately after liver transplantation. Hepatology 2002; 35: 680-7.

[13]

Doherty D. G., Norris S., Madrigal-Estebas L. et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and ThO cytokine secretion patterns. J. Immunol. 2002; 163: 2314-21.

[14]

Ishiyama K., Ohdan H., Ohira M. et al. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 2006; 43: 362-72.

[15]

Tateno C, Yoshizane Y., Saito N. et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 2004; 165: 901-12.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

64

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/